- Home
- TXMD vs SYNX Comparison
TXMD vs SYNX Comparison
Compare TXMD & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- SYNX
- Stock Information
- Founded
- TXMD 2008
- SYNX 2005
- Country
- TXMD United States
- SYNX Israel
- Employees
- TXMD N/A
- SYNX N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- SYNX
- Sector
- TXMD Health Care
- SYNX
- Exchange
- TXMD Nasdaq
- SYNX Nasdaq
- Market Cap
- TXMD 12.3M
- SYNX 10.2M
- IPO Year
- TXMD N/A
- SYNX 2024
- Fundamental
- Price
- TXMD $1.19
- SYNX $1.61
- Analyst Decision
- TXMD
- SYNX
- Analyst Count
- TXMD 0
- SYNX 0
- Target Price
- TXMD N/A
- SYNX N/A
- AVG Volume (30 Days)
- TXMD 511.6K
- SYNX 51.7K
- Earning Date
- TXMD 11-12-2025
- SYNX 09-26-2025
- Dividend Yield
- TXMD N/A
- SYNX N/A
- EPS Growth
- TXMD N/A
- SYNX N/A
- EPS
- TXMD N/A
- SYNX N/A
- Revenue
- TXMD $2,559,000.00
- SYNX $6,003,000.00
- Revenue This Year
- TXMD $427.09
- SYNX $32.35
- Revenue Next Year
- TXMD N/A
- SYNX N/A
- P/E Ratio
- TXMD N/A
- SYNX N/A
- Revenue Growth
- TXMD 156.93
- SYNX N/A
- 52 Week Low
- TXMD $0.70
- SYNX $1.37
- 52 Week High
- TXMD $2.44
- SYNX $6.49
- Technical
- Relative Strength Index (RSI)
- TXMD 53.55
- SYNX 50.95
- Support Level
- TXMD $1.19
- SYNX $1.56
- Resistance Level
- TXMD $1.28
- SYNX $1.67
- Average True Range (ATR)
- TXMD 0.13
- SYNX 0.07
- MACD
- TXMD 0.01
- SYNX -0.00
- Stochastic Oscillator
- TXMD 23.88
- SYNX 33.78
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About SYNX Silynxcom Ltd.
Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.